Safety of Fingolimod in Patients with Multiple Sclerosis Switched from Natalizumab: Results from TRANSITION―A 2-Year, Multicenter, Observational, Cohort Study

MS Treatments

Jahr

Publikationsjahr
2022

Autoren

Autorenliste der Publikation
Butzkueven H, Giacomini PS, Cohan S, Ziemssen T, Sienkiewicz D, Zhang Y, Geissbühler Y, Silva D, Tomic D, Kropshofer H, Trojano M.

Verlag

Publisher-Information
Brain Sci. 2022 Feb 4;12(2):215.

Link

Zur Publikation (externer Server)
https://doi.org/10.3390/brainsci12020215

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
Treatments2022